JUNO

Juno Therapeutics, Inc.
JUNO

Overview Fund Activity
Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

154 hedge funds and large institutions have $2.54B invested in Juno Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 55 increasing their positions, 23 reducing their positions, and 23 closing their positions.

Holders
154
Holders Change
+34
Holders Change %
+28.33%
% of All Funds
4.15%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
57
Increased
55
Reduced
23
Closed
23
Calls
$20.3M
Puts
$51.1M
Net Calls
-$30.8M
Net Calls Change
-$24.1M

Top Buyers

1
Capital World Investors
1
Capital World Investors
California
$202M
2
State Street
2
State Street
Massachusetts
$28.4M
3
BB
3
BB Biotech
Switzerland
$24M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$24.3M
5
Citadel Advisors
5
Citadel Advisors
Florida
$19.1M

Top Sellers

1
VM
1
VHCP Management
New York
$4.81M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$0
3
CM
3
Crestline Management
Texas
$1.39B
4
PHS
4
PFM Health Sciences
California
$6.34M
5
Allianz Asset Management
5
Allianz Asset Management
Germany
$0
Name Market Value Shares Shares
Change 		Shares
Change %
WP
176
WealthPLAN Partners
Nebraska
– – -100 Closed
PG
177
PEAK6 Group
Illinois
– – – –
TWMP
178
Taylor Wealth Management Partners
Massachusetts
$0 9 +9 New
4 5 6 7
8